Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

Last night, a year after his first show for Tom Ford, Haider Ackermann introduced his fall 2026 collection with a set of beautifully tailored all-black and all-white looks. The first models sported ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

We humans have long viewed ourselves as the pinnacle of evolution. People label other species as “primitive” or “ancient” and use terms like “higher” and “lower” animals. This anthropocentric ...

“Primitive War” is returning for another round of Vietnam War-meets-dinosaur action. “Primitive War 2” is in the works, Variety can confirm. Luke Sparke is returning to write, direct and produce the ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Following the departure of Dylan Groenewegen to Unibet Rose Rockets for 2026, Jayco-AlUla have re-strengthened their sprinting lineup with the signing of Pascal Ackermann, who joins on a two-year deal ...

Recursion Pharmaceuticals currently has the industry's largest AI supercomputer. It also has partnerships with major drugmakers, but these have yet to yield major wins. Recursion'a lack of clinical ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...